Insider buying keeps Annexon Inc. in focus—director Carson H. purchases 8,000 shares amid a 4‑month dip, signaling confidence in its clinical pipeline.
Insider sales at Annexon Inc. on Feb 18, 2026 reveal a tax‑planning move, not a strategic shift—yet the company’s Phase II pipeline and Fast‑Track prospects remain key.